Back to Search
Start Over
Resverlogix Announces Milestone ApoA-l/HDL Proof-of-Concept Data; NexVas(TM) PR lead molecule RVX-208 increases ApoA-l/HDL in monkeys
- Source :
- Internet Wire. April 25, 2007
- Publication Year :
- 2007
-
Abstract
- CALGARY, ALBERTA, Apr 25, 2007 (MARKET WIRE via COMTEX) -- Resverlogix Corp. ('Resverlogix') (TSX: RVX) announced today that the Company has released pivotal proof-of-concept data in non-human primates for the […]
- Subjects :
- Company public relations
Cholesterol
Public relations
Monkeys
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Internet Wire
- Publication Type :
- News
- Accession number :
- edsgcl.162589456